AURKA is one of the downstream targets of MAPK1/ERK2 in pancreatic cancer
The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
DUSP6/MKP-3, a specific inhibitor of MAPK1/ERK2, frequently loses its expression in primary pancreatic cancer tissues. This evidence suggests that constitutive activation of MAPK1 synergistically induced by frequent mutation of KRAS2 and the loss of function of DUSP6 plays key roles in pancreatic carcinogenesis and progression. By profiling of gene expressions associated with downregulation of MAPK1 induced by exogenous overexpression of DUSP6 in pancreatic cancer cells, we found that AURKA/STK15, the gene encoding Aurora-A kinase, which plays key roles in cellular mitosis, was among the downregulated genes along with its related genes, which included AURKB, TPX2 and CENPA. An association of expression and promoter activity of AURKA with MAPK activity was verified. Knockdown of ETS2 resulted in a reduction of AURKA expression. These results indicate that AURKA is a direct target of the MAPK pathway and that its overexpression in pancreatic cancer is induced by hyperactivation of the pathway, at least via ETS2.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On one hand, aberrant activation of KRAS and downstream MAPK/ERK signaling promotes AURKA overexpression [129–131].”
From Differential Response and Resistance to KRAS-Targeted Therapy (2025) · cites this paper as [131]
Citations
Cites
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells
Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., & Tuschl, T. (2001) · Nature · doi:10.1038/35078107 · Cited by 9,456 · cited 2×
“…residues (dTdT) overhanging at the 30 end to knock down the expressions of ETS2, ELK1 and LMNA, including 50-CAACAGGCUUGGAUUCCAU-30 for ETS2, 50-GGCAAUGGCCACAUCAUCU-30 for ELK1 and 50-CUGGACUUCCAGAAGAACA-30 for LMNA (Elbashir et al., 2001), were purchased from Japan Bioservice (Asaka, Japan).”
MethodProtein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling
Hunter, T. (1995) · Cell · doi:10.1016/0092-8674(95)90405-0 · Cited by 2,950
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation
Zhou, H., Kuang, J., Zhong, L., Kuo, W.-L., Gray, J., Sahin, A., Brinkley, B., & Sen, S. (1998) · Nature Genetics · doi:10.1038/2496 · Cited by 1,276 · cited 1×
“AURKA encodes AURKA/STK15/ Aurora-A kinase, which is an essential molecule involved in regulating the functions of centrosomes, spindles and kinetochores and is therefore required for proper mitosis of cells (Zhou et al., 1998; Marumoto et al., 2005).”
BackgroundWang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221
A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers
Bischoff, J. R. (1998) · The EMBO Journal · doi:10.1093/emboj/17.11.3052 · Cited by 1,216 · cited 1×
“…is overexpressed in various cancer cells, including pancreatic cancer, and is associated with high-grade of tumors and poor survival of patients with cancer (Sen et al., 1997; Bischoff et al., 1998; Tanner et al., 2000; Miyoshi et al., 2001; Li et al., 2003; Jeng et al., 2004; Tong et al., 2004).”
BackgroundTargeting the mitogen-activated protein kinase cascade to treat cancer
Sebolt-Leopold, J. S., & Herrera, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1503 · Cited by 1,108
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
Keyse, S. M. (2000) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)00075-7 · Cited by 807 · cited 1×
“DUSP6 is a phosphatase strictly specific for MAPK1; it forms a feedback loop for physiological regulation of MAPK activity (Keyse, 2000).”
BackgroundAurora-A — A guardian of poles
Marumoto, T., Zhang, D., & Saya, H. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1526 · Cited by 697 · cited 5×
“2; however, an overexpression without gene amplification is also frequently observed (Marumoto et al., 2005).”
BackgroundInfluentialMolecular biology of the Ets family of transcription factors
Oikawa, T., & Yamada, T. (2003) · Gene · doi:10.1016/s0378-1119(02)01156-3 · Cited by 688 · cited 2×
“ETS2 is a transcription factor belonging to the ETS family of transcription factors (Oikawa and Yamada, 2003).”
BackgroundHunter, T., & Pines, J. (1991) · Cell · doi:10.1016/0092-8674(91)90028-w · Cited by 688 · cited 2×
“They included genes encoding cyclins such as CCNA2, CCNB1, CCNB2 and CCNE2 (Hunter and Pines, 1991), kinetocore-related molecules such as AURKA, AURKB, CENPA and CENPF (Hussein and Taylor, 2002; Kunitoku et al., 2003; Marumoto et al., 2005), microtubule-associated molecules such as TPX2 and KIF2C (Kufer et al., 2002;…”
BackgroundPhosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53
Katayama, H., Sasai, K., Kawai, H., Yuan, Z.-M., Bondaruk, J., Suzuki, F., Fujii, S., Arlinghaus, R. B., Czerniak, B. A., & Sen, S. (2004) · Nature Genetics · doi:10.1038/ng1279 · Cited by 588 · cited 1×
“Its overexpression can induce checkpoint disruption by interfering with p53 function and tetraploidization, possibly leading to aneuploidy (Katayama et al., 2004; Liu et al., 2004; Zhang et al., 2004).”
BackgroundHuman TPX2 is required for targeting Aurora-A kinase to the spindle
Kufer, T. A., Silljé, H. H. W., Körner, R., Gruss, O. J., Meraldi, P., & Nigg, E. A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200204155 · Cited by 587 · cited 2×
“…CENPA and CENPF (Hussein and Taylor, 2002; Kunitoku et al., 2003; Marumoto et al., 2005), microtubule-associated molecules such as TPX2 and KIF2C (Kufer et al., 2002; Hunter et al., 2003), RRM1 encoding ribonucleotide reductase (Parker et al., 1995), POLQ encoding DNA polymerase theta (Sharief…”
BackgroundASC, a Novel 22-kDa Protein, Aggregates during Apoptosis of Human Promyelocytic Leukemia HL-60 Cells
Masumoto, J., Taniguchi, S., Ayukawa, K., Sarvotham, H., Kishino, T., Niikawa, N., Hidaka, E., Katsuyama, T., Higuchi, T., & Sagara, J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33835 · Cited by 541 · cited 3×
“However, only a limited fraction of these genes are known to be involved in such phenotypes, including the pro-apoptotic gene PYCARD (Masumoto et al., 1999) and some genes known to be involved in negative regulation of cell proliferation, including TGFB2, RARRES3 and IFITM1 (de Martin et al., 1987;…”
BackgroundInfluentialSen, S., Zhou, H., & White, R. A. (1997) · Oncogene · doi:10.1038/sj.onc.1201065 · Cited by 482 · cited 1×
“…is overexpressed in various cancer cells, including pancreatic cancer, and is associated with high-grade of tumors and poor survival of patients with cancer (Sen et al., 1997; Bischoff et al., 1998; Tanner et al., 2000; Miyoshi et al., 2001; Li et al., 2003; Jeng et al., 2004; Tong et al., 2004).”
BackgroundHunter, A. W., Caplow, M., Coy, D. L., Hancock, W. O., Diez, S., Wordeman, L., & Howard, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00049-2 · Cited by 386 · cited 1×
“…and Taylor, 2002; Kunitoku et al., 2003; Marumoto et al., 2005), microtubule-associated molecules such as TPX2 and KIF2C (Kufer et al., 2002; Hunter et al., 2003), RRM1 encoding ribonucleotide reductase (Parker et al., 1995), POLQ encoding DNA polymerase theta (Sharief et al., 1999), PRIM1…”
Backgroundde Martin, R., Haendler, B., Hofer-Warbinek, R., Gaugitsch, H., Wrann, M., Schlüsener, H., Seifert, J. M., Bodmer, S., Fontana, A., & Hofer, E. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02700.x · Cited by 384 · cited 1×
“…genes are known to be involved in such phenotypes, including the pro-apoptotic gene PYCARD (Masumoto et al., 1999) and some genes known to be involved in negative regulation of cell proliferation, including TGFB2, RARRES3 and IFITM1 (de Martin et al., 1987; DiSepio et al., 1998; Kita et al., 2003).”
BackgroundAurora-A Abrogation of p53 DNA Binding and Transactivation Activity by Phosphorylation of Serine 215
Liu, Q., Kaneko, S., Yang, L., Feldman, R. I., Nicosia, S. V., Chen, J., & Cheng, J. Q. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406802200 · Cited by 334 · cited 1×
“Its overexpression can induce checkpoint disruption by interfering with p53 function and tetraploidization, possibly leading to aneuploidy (Katayama et al., 2004; Liu et al., 2004; Zhang et al., 2004).”
BackgroundPancreatic Cancer Registry in Japan: 20 Years of Experience
Matsuno, S., Egawa, S., Fukuyama, S., Motoi, F., Sunamura, M., Isaji, S., Imaizumi, T., Okada, S., Kato, H., Suda, K., et al. (2004) · Pancreas · doi:10.1097/00006676-200404000-00002 · Cited by 307 · cited 2×
“Pancreatic cancer is one of the most lethal malignancies in Japan as well as in Western countries (Matsuno et al., 2004).”
BackgroundOverexpression and Amplification of Aurora-A in Hepatocellular Carcinoma
Jeng, Y.-M., Peng, S.-Y., Lin, C.-Y., & Hsu, H.-C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1057-03 · Cited by 304 · cited 1×
“…is overexpressed in various cancer cells, including pancreatic cancer, and is associated with high-grade of tumors and poor survival of patients with cancer (Sen et al., 1997; Bischoff et al., 1998; Tanner et al., 2000; Miyoshi et al., 2001; Li et al., 2003; Jeng et al., 2004; Tong et al., 2004).”
BackgroundKunitoku, N., Sasayama, T., Marumoto, T., Zhang, D., Honda, S., Kobayashi, O., Hatakeyama, K., Ushio, Y., Saya, H., & Hirota, T. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00364-2 · Cited by 248 · cited 1×
“…CCNB1, CCNB2 and CCNE2 (Hunter and Pines, 1991), kinetocore-related molecules such as AURKA, AURKB, CENPA and CENPF (Hussein and Taylor, 2002; Kunitoku et al., 2003; Marumoto et al., 2005), microtubule-associated molecules such as TPX2 and KIF2C (Kufer et al., 2002; Hunter et al., 2003),…”
BackgroundBRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) Mutations in Distinct Subsets of Pancreatic Cancer
Calhoun, E. S., Jones, J. B., Ashfaq, R., Adsay, V., Baker, S. J., Valentine, V., Hempen, P. M., Hilgers, W., Yeo, C. J., Hruban, R. H., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63485-2 · Cited by 232 · cited 1×
“A small fraction of primary pancreatic cancer cells without mutations of KRAS2 harbor gain-offunction mutations of BRAF (Calhoun et al., 2003).”
BackgroundMiyoshi, Y., Iwao, K., Egawa, C., & Noguchi, S. (2001) · International Journal of Cancer · doi:10.1002/ijc.1200 · Cited by 227 · cited 1×
“…is overexpressed in various cancer cells, including pancreatic cancer, and is associated with high-grade of tumors and poor survival of patients with cancer (Sen et al., 1997; Bischoff et al., 1998; Tanner et al., 2000; Miyoshi et al., 2001; Li et al., 2003; Jeng et al., 2004; Tong et al., 2004).”
BackgroundHata, T., Furukawa, T., Sunamura, M., Egawa, S., Motoi, F., Ohmura, N., Marumoto, T., Saya, H., & Horii, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3981 · Cited by 217 · cited 4×
“Recently, Hata et al. (2005) demonstrated that depletion of AURKA by RNA interference in human pancreatic cancer cells resulted in marked growth suppression in vitro, abolishment of tumorigenesity in vivo and induction of sensitivity to taxanes, chemotherapeutic drugs interfering with the functions…”
BackgroundMethodSelf-citationPotential Tumor Suppressive Pathway Involving DUSP6/MKP-3 in Pancreatic Cancer
Furukawa, T., Sunamura, M., Motoi, F., Matsuno, S., & Horii, A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64315-5 · Cited by 216 · cited 6×
“Adenovirus-mediated exogenous overexpression of DUSP6 induced dephosphorylation of MAPK1 and subsequent growth suppression and apoptosis in pancreatic cancer cells with loss of expression of endogenous DUSP6 (Furukawa et al., 2003).”
BackgroundMethodSelf-citationRas/Mitogen-Activated Protein Kinase Signaling Activates Ets-1 and Ets-2 by CBP/p300 Recruitment
Foulds, C. E., Nelson, M. L., Blaszczak, A. G., & Graves, B. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.24.10954-10964.2004 · Cited by 190 · cited 2×
“ETS1 is also interesting because it encodes a transcription factor mediating transcription of some cancer-related genes and is known to be one of the downstream target genes of MAPK1 (Foulds et al., 2004).”
BackgroundDiSepio, D., Ghosn, C., Eckert, R. L., Deucher, A., Robinson, N., Duvic, M., Chandraratna, R. A. S., & Nagpal, S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14811 · Cited by 171 · cited 1×
“…genes are known to be involved in such phenotypes, including the pro-apoptotic gene PYCARD (Masumoto et al., 1999) and some genes known to be involved in negative regulation of cell proliferation, including TGFB2, RARRES3 and IFITM1 (de Martin et al., 1987; DiSepio et al., 1998; Kita et al., 2003).”
BackgroundTong, T., Zhong, Y., Kong, J., Dong, L., Song, Y., Fu, M., Liu, Z., Wang, M., Guo, L., Lu, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0806 · Cited by 159 · cited 1×
“…is overexpressed in various cancer cells, including pancreatic cancer, and is associated with high-grade of tumors and poor survival of patients with cancer (Sen et al., 1997; Bischoff et al., 1998; Tanner et al., 2000; Miyoshi et al., 2001; Li et al., 2003; Jeng et al., 2004; Tong et al., 2004).”
BackgroundK-ras mutation and pancreatic adenocarcinoma
Caldas, C., & Kern, S. E. (1995) · International Journal of Pancreatology · doi:10.1007/bf02825415 · Cited by 156
Farnesylation of Cenp-F is required for G2/M progression and degradation after mitosis
Hussein, D., & Taylor, S. S. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.17.3403 · Cited by 155
Zhang, D., Hirota, T., Marumoto, T., Shimizu, M., Kunitoku, N., Sasayama, T., Arima, Y., Feng, L., Suzuki, M., Takeya, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1208153 · Cited by 147 · cited 1×
“Its overexpression can induce checkpoint disruption by interfering with p53 function and tetraploidization, possibly leading to aneuploidy (Katayama et al., 2004; Liu et al., 2004; Zhang et al., 2004).”
BackgroundSeiki, M., & Yana, I. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01484.x · Cited by 138 · cited 1×
“Genes of interest in terms of implication in cancer progression were MMP1 and EPHA2; both are associated with invasion and metastasis (Kinch and Carles-Kinch, 2003; Seiki and Yana, 2003).”
BackgroundFurukawa, T., Fujisaki, R., Yoshida, Y., Kanai, N., Sunamura, M., Abe, T., Takeda, K., Matsuno, S., & Horii, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800383 · Cited by 137 · cited 1×
“We further found that DUSP6 was frequently underexpressed in invasive carcinoma of the pancreas despite its overexpression in precancerous dysplastic lesions/pancreatic intraepithelial neoplasia (Furukawa et al., 2003, 2005).”
BackgroundSelf-citationAbrogation of DUSP6 by hypermethylation in human pancreatic cancer
Xu, S., Furukawa, T., Kanai, N., Sunamura, M., & Horii, A. (2005) · Journal of Human Genetics · doi:10.1007/s10038-005-0235-y · Cited by 137 · cited 2×
“The quantitative real-time PCR assay was performed as described previously (Xu et al., 2005).”
BackgroundMethodSelf-citationOverexpression and functional alterations of the EphA2 tyrosine kinase in cancer
Kinch, M. S., & Carles‐Kinch, K. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022546620495 · Cited by 136 · cited 1×
“Genes of interest in terms of implication in cancer progression were MMP1 and EPHA2; both are associated with invasion and metastasis (Kinch and Carles-Kinch, 2003; Seiki and Yana, 2003).”
BackgroundMansour, S. J., Candia, J. M., Matsuura, J. E., Manning, M. C., & Ahn, N. G. (1996) · Biochemistry · doi:10.1021/bi961854s · Cited by 133 · cited 3×
“The cDNAs encoding the constitutive active MAP2K1, MAP2K1D44-51/S218E/S222E, were constructed based on the pcDNA-MAP2K1 clone constructed above as described elsewhere (Mansour et al., 1996).”
BackgroundMethodInfluentialFrequent gain of copy number on the long arm of chromosome 20 in human pancreatic adenocarcinoma
Fukushige, S., Waldman, F. M., Kimura, M., Abe, T., Furukawa, T., Sunamura, M., Kobari, M., & Horii, A. (1997) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199707)19:3<161::aid-gcc5>3.0.co;2-w · Cited by 122 · cited 1×
“Fluorescence in situ hybridization was performed using the BAC clones b57E22 and RMC20L116 harboring the centromeric sequence of chromosome 20, as described previously (Fukushige et al., 1997).”
MethodSelf-citationSharief, F. S., Vojta, P. J., Ropp, P. A., & Copeland, W. C. (1999) · Genomics · doi:10.1006/geno.1999.5843 · Cited by 118 · cited 1×
“…KIF2C (Kufer et al., 2002; Hunter et al., 2003), RRM1 encoding ribonucleotide reductase (Parker et al., 1995), POLQ encoding DNA polymerase theta (Sharief et al., 1999), PRIM1 encoding DNA primase (Stadlbauer et al., 1994), MCM4 encoding DNA replication–initiation factor (Musahl et al., 1995)…”
Tanaka, M., Ueda, A., Kanamori, H., Ideguchi, H., Yang, J., Kitajima, S., & Ishigatsubo, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108252200 · Cited by 115 · cited 2×
“We chose ELK1 and ETS2 as candidates for further analysis, because ETS1 was known not to be involved in the promoter activity (Tanaka et al., 2002).”
BackgroundMethodA Human Homologue of the Yeast Replication Protein Cdc21
Musahl, C., Schulte, D., Burkhart, R., & Knippers, R. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.1096g.x · Cited by 86 · cited 1×
“…ribonucleotide reductase (Parker et al., 1995), POLQ encoding DNA polymerase theta (Sharief et al., 1999), PRIM1 encoding DNA primase (Stadlbauer et al., 1994), MCM4 encoding DNA replication–initiation factor (Musahl et al., 1995) and RFC4 encoding DNA replication factor (Wang et al., 2000).”
A Human Homologue of the Yeast Replication Protein Cdc21. Interactions with Other Mcm Proteins
Musahl, C., Schulte, D., Burkhart, R., & Knippers, R. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20660.x · Cited by 84
Rojanala, S., Han, H., Muñoz, R. M., Browne, W., Nagle, R. B., Hoff, D. D. V., & Bearss, D. J. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.451.3.4 · Cited by 83
DNA replication in vitro by recombinant DNA‐polymerase‐α‐primase
STADLBAUER, F., BRUECKNER, A., REHFUESS, C., ECKERSKORN, C., LOTTSPEICH, F., FÖRSTER, V., TSENG, B. Y., & NASHEUER, H. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18925.x · Cited by 78 · cited 1×
“…RRM1 encoding ribonucleotide reductase (Parker et al., 1995), POLQ encoding DNA polymerase theta (Sharief et al., 1999), PRIM1 encoding DNA primase (Stadlbauer et al., 1994), MCM4 encoding DNA replication–initiation factor (Musahl et al., 1995) and RFC4 encoding DNA replication factor (Wang et…”
BackgroundKimura, M., Abe, T., Sunamura, M., Matsuno, S., & Horii, A. (1996) · Genes, Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199610)17:2<88::aid-gcc3>3.0.co;2-x · Cited by 75 · cited 1×
“1 (Kimura et al., 1996, 1998).”
Self-citationGenomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer
Furukawa, T., Yatsuoka, T., Youssef, E. M., Abe, T., Yokoyama, T., Fukushige, S., Soeda, E., Hoshi, M., Hayashi, Y., Sunamura, M., et al. (1998) · Cytogenetic and Genome Research · doi:10.1159/000015091 · Cited by 74 · cited 1×
“We found that DUSP6/MKP-3 is a candidate tumor suppressor gene in this locus (Furukawa et al., 1998).”
BackgroundSelf-citationFears, S. C., Vignon, C., Bohlander, S. K., Smith, S. D., Rowley, J. D., & Nucifora, G. (1996) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199610)17:2<127::aid-gcc8>3.0.co;2-7 · Cited by 59
Self-citationThe Human PMS2L Proteins Do Not Interact with hMLHl, a Major DNA Mismatch Repair Protein
Eondo, E., Horii, A., & Fukushige, S.-I. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022354 · Cited by 52 · cited 1×
“Immunoblotting was performed as described previously (Kondo et al., 1999).”
Self-citationAlternative splicing of hMSH2 in normal human tissues
Mori, Y., Shiwaku, H. O., Fukushige, S., Wakatsuki, S., Sato, M., Nukiwa, T., & Horii, A. (1997) · Human Genetics · doi:10.1007/s004390050411 · Cited by 48 · cited 1×
“Complementary DNA was generated by the reverse transcription method using 10mg of the total RNA, as described previously (Mori et al., 1997).”
MethodSelf-citationMolecular Pathology of Pancreatic Cancer
Furukawa, T., & Horii, A. (2004) · Pancreas · doi:10.1097/00006676-200404000-00007 · Cited by 40 · cited 2×
“These results indicated that constitutive activation of MAPK synergistically induced by the frequent mutation of KRAS2 and the loss of expression of DUSP6 is crucial for the growth and survival of pancreatic cancer cells (Furukawa and Horii, 2004).”
BackgroundResultSelf-citationRegenerative lesions in ulcerative colitis are characterized by microsatellite mutation
Heinen, C. D., Noffsinger, A. E., Belli, J., Straughen, J. E., Fischer, J. E., Groden, J. L., & Fenoglio‐Preiser, C. M. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199707)19:3<156::aid-gcc4>3.0.co;2-x · Cited by 36
Self-citationKita, K., Sugaya, S., Zhai, L., Yu-ling, W., Wano, C., Chigira, S., Nomura, J., Takahashi, S., Ichinose, M., & Suzuki, N. (2003) · Radiation Research · doi:10.1667/rr3039 · Cited by 33 · cited 1×
“…genes are known to be involved in such phenotypes, including the pro-apoptotic gene PYCARD (Masumoto et al., 1999) and some genes known to be involved in negative regulation of cell proliferation, including TGFB2, RARRES3 and IFITM1 (de Martin et al., 1987; DiSepio et al., 1998; Kita et al., 2003).”
BackgroundHoshi, M., Otagiri, N., Shiwaku, H., Asakawa, S., Shimizu, N., Kaneko, Y., Ohi, R., Hayashi, Y., & Horii, A. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1108 · Cited by 32
Self-citationParker, N. J., Begley, C. G., & Fox, R. M. (1995) · Genomics · doi:10.1006/geno.1995.1043 · Cited by 19 · cited 1×
“…2005), microtubule-associated molecules such as TPX2 and KIF2C (Kufer et al., 2002; Hunter et al., 2003), RRM1 encoding ribonucleotide reductase (Parker et al., 1995), POLQ encoding DNA polymerase theta (Sharief et al., 1999), PRIM1 encoding DNA primase (Stadlbauer et al., 1994), MCM4 encoding…”
BackgroundYamanaka, S., Sunamura, M., Furukawa, T., Sun, L., Lefter, L. P., Abe, T., Yatsuoka, T., Fujimura, H., Shibuya, E., Kotobuki, N., et al. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700160 · Cited by 17 · cited 1×
“The semiquantitative PCR was performed according to methods described previously (Yamanaka et al., 2004) in 25 ml of reaction buffer and using the GeneAmp PCR system 9700 (Applied Biosystems, Foster City, CA, USA).”
MethodSelf-citation
Cited by
Roles of Aurora Kinases in Mitosis and Tumorigenesis
Fu, J., Bian, M., Jiang, Q., & Zhang, C. (2007) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0208 · Cited by 614
“Aurora Kinases in Other Signaling Pathways and Tumorigenesis Recent studies found that Aurora-A is a downstream target of mitogen-activated protein kinase 1/ER2 in pancreatic cancer (101).”
BackgroundHung, L.-Y., Tseng, J. T., Lee, Y.-C., Xia, W., Wang, Y.-N., Wu, M.-L., Chuang, Y.-H., Lai, C.-H., & Chang, W.-C. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn417 · Cited by 196
“Furthermore, the DUSP6/MKP-3 (dual specificity phosphatase 6/MAPK phosphatase-3, a candidate tumor suppressor gene and a specific phosphatase forMAPK1), can downregulateAurora-A gene expression in pancreatic cancer (11).”
BackgroundWidodo, N., Priyandoko, D., Shah, N., Wadhwa, R., & Kaul, S. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013536 · Cited by 157
“TPX2 is a microtubule-associated protein that functions as an allosteric regulator of Aurora-A, an oncogene with essential role in centrosome maturation and chromosome segregation during mitosis requiring assembly and maintenance of a bipolar spindle [21–23].”
BackgroundThe long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration
Cheng, Y., Jutooru, I., Chadalapaka, G., Corton, J. C., & Safe, S. H. (2015) · Oncotarget · doi:10.18632/oncotarget.3450 · Cited by 150
“Since AURKA (Aurora-A kinase) plays an important multifunctional role in pancreatic cancer [19–21], we further investigated the function and regulation of AURKA in pancreatic cancer cells.”
BackgroundMuhammad, K. A., Nur, A. A., Shafie, N. H., Narazah, M. Y., & Razak, S. R. A. (2018) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2017.0107 · Cited by 154
Metadata
- Authors
- Furukawa, T., Kanai, N., Shiwaku, H. O., Soga, N., Uehara, A., & Horii, A.
- Affiliations
- Tokyo Women's Medical University (JP)
- Tohoku University (JP)
- Corresponding author
- Furukawa, T
- Venue
- Oncogene
- Published
- 2006-03-13
- Volume
- 25
- Issue
- 35
- Pages
- 4831-4839
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2048245178
- Cited by
- 135
- References
- 50
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 6 · 2023: 9 · 2022: 10 · 2021: 9 · 2020: 6 · 2019: 5 · 2018: 8 · 2017: 4 · 2016: 8 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 6
- FWCI
- 4.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Pancreas Research Foundation of Japan
- Foundation for Promotion of Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- AURKA, pancreatic cancer, KRAS mutation, ETS2, downstream target genes, mitosis, gene expression profiling, promoter activity, TPX2, CENP-A
- MeSH terms
- Cell Line, Cell Line, Transformed, Humans, Pancreatic Neoplasms, Gene Expression Regulation, Neoplastic, Protein Tyrosine Phosphatases, Protein Serine-Threonine Kinases, Mitogen-Activated Protein Kinase 1, Gene Expression Profiling, MAP Kinase Signaling System, Cell Line, Tumor, Dual Specificity Phosphatase 6, Aurora Kinase A, Aurora Kinase B, Aurora Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.